Smooth Drug Development March 2024 News Release
Published on Friday April 05, 2024
We are working on the following new projects: • We received a contract for a phase I study with Pembrolizumab.
Smooth Drug Development February 2024 News Release
Published on Tuesday March 05, 2024
We are working on the following new projects: • A contract for a phase III study with Aflibercept was signed.
Smooth Drug Development January 2024 News Release
Published on Monday February 05, 2024
January We are working on the following new projects: • We have successfully passed quality control of a global company and we are finalizing a contract for data management activities in observational programs.
Smooth Drug Development December 2023 News Release
Published on Friday January 05, 2024
We are working on the following new projects: • We signed a contract for a phase III trial in patients with nasopharyngitis.
Smooth Drug Development November 2023 News Release
Published on Wednesday December 06, 2023
We are working on the following new projects: • We won a bidding for an adalimumab trial, phase I.
Smooth Drug Development October 2023 News Release
Published on Sunday November 05, 2023
October We are working on the following new projects: • We signed a contract for medical writing activities for a phase III trial with glucosamine + chondroitin sulfate.
Smooth Drug Development September 2023 News Release
Published on Thursday October 05, 2023
We are working on the following new projects: • We signed a contract for medical writing activities for a BE trial with our long-term Client.
Smooth Drug Development August 2023 News Release
Published on Tuesday September 05, 2023
August We are working on the following new projects: • We were awarded with medical writing activities for bioequivalence trials with Triptorelin.
Smooth Drug Development July 2023 News Release
Published on Saturday August 05, 2023
We are working on the following new projects: • We were awarded with 6 bioequivalence trials with Gliclazide, Liraglutide, Vildagliptin, Dolutegravir and Empagliflozin 10 mg and 25 mg.
Smooth Drug Development June 2023 News Release
Published on Wednesday July 05, 2023
We are working on the following new projects: • We signed a contract for a bioequivalence trial with Edoxaban.
Smooth Drug Development May 2023 News Release
Published on Monday June 05, 2023
We are working on the following new projects: • We signed 2 contracts for bioequivalence trials with Rivaraxoban.
Happy Clinical Trials Day!
Published on Saturday May 20, 2023
His report thus illustrates his awareness of the need to guard against selection bias and shows how he attempted to hold constant potential confounding factors - clinical condition, environment, and basic diet
Smooth Drug Development April 2023 News Release
Published on Friday May 05, 2023
April We are working on the following new projects: • We have been awarded several bioequivalence studies
Smooth Drug Development March 2023 News Release
Published on Wednesday April 05, 2023
We were awarded with several bioequivalence trials for full services activities (Umifenovir, Tadalafil, Ipidacrine, Sertraline, Silodosine).
Seminar on European Pharma & Medical Device Regulation and Overseas Clinical Trial Strategies
Published on Thursday March 30, 2023
Smooth together with Chinese colleagues hosts a seminar on European Pharma & Medical Device Regulation and Overseas Clinical Trial Strategies on 3 April. Feel free to join.